Intelligence · Clinical pipeline
Infectious disease · Phase I
Infectious disease programs at Phase I — ClinicalTrials.gov pipeline intelligence.
Programs 6
Quick answer
Infectious disease Phase I programs: NovaPharmaNews indexes 6 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- United Therapeutics Europe 23 programs
- ENANTA PHARMACEUTICALS 14 programs
- Vertex Pharmaceuticals (Australia) 11 programs
- BRIGHT MINDS BIOSCIENCES 10 programs
- Chinese Academy of 10 programs
- ASSEMBLY BIOSCIENCES 9 programs
- Aligos Therapeutics 8 programs
- Anaxis Pharma 8 programs
- Sunshine Guojian Pharmaceutical 8 programs
- INOVIO Pharmaceuticals 7 programs
- MSD Merck Sharp 6 programs
- Sinovac Research and 6 programs
Pipeline programs
-
Chloroquine
GlaxoSmithKline
Malaria
1 trial -
D/ChAd63-CA
United Therapeutics Europe Ltd
Malaria
1 trial -
FMP012 with AS01B adjuvant system
United Therapeutics Europe Ltd
Malaria
1 trial -
FMP1/AS02A
United Therapeutics Europe Ltd
Malaria
1 trial -
Group 1: 10 ug FMP012 with 2 ug GLA-SE
United Therapeutics Europe Ltd
Malaria
1 trial -
Plasmodium falciparum Malaria Protein 010 (FMP010)
United Therapeutics Europe Ltd
Malaria
1 trial
Frequently asked questions
How many infectious disease Phase I programs exist?
6 programs match both the therapeutic area and stage filters in our published index.